Guidance Document  
 
A guidance document issued by the Ministry for Primary Industries  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Zoo Bovidae, Giraffidae and 
Tragulidae (Live Animals 
and Semen)  
ZOOUNGLE.SPE  
[Document Date]  
 Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  1 of 39 
 
 
 Title 
Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen) . 
About this document  
This guidance document contains information about acceptable ways of ensuring compliance with the 
requirements in t he Import Health Standard ( IHS): Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and 
Semen) . 
Any guidance on how to comply with the applicable requirements may not be the only way to achieve 
compliance. Stakeholders are encouraged to discuss departures from the approaches outlined in this 
guidance document wi th the Ministry for Primary Industries (MPI) to avoid expending resources on the 
development of alternative approaches which may later be considered unsuitable.  
The term “must” is not typically used in guidance. In this particular document if the term “mus t” is used, it is 
used in the context of quoting or paraphrasing the requirements set out in the related IHS: Zoo Bovidae, 
Giraffidae and Tragulidae (Live Animals and Semen) . 
Related Requirements  
Import Health Standard: Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
Document  history  
Refer to Appendix 1.  
Contact Details  
For further information and questions about this guidance document, please contact:  
 
Ministry for Primary Industries  
Biosecurity New Zealand  
Animal Imports  
PO Box 2526  
Wellington 6140  
Email: animal.imports@mpi.govt.nz  
Disclaimer  
This guidance does not constitute, and should not be regarded as, legal advice . While every effort has been 
made to ensure the information in this guidance is accurate, the Ministry for Primary Industries does not accept 
any responsibility or liability whatsoever for any error of fact, omission, interpretation or opinion that may be 
present, however it may have occurred.  
Copyright  
Crown copyright ©. This copyright work is licensed under the Creative Commons Attribution 3.0 New Zealand 
licence. In essence, you are free to copy, distribute and adapt the work, as long as you attribu te the work to the Ministry for Primary 
Industries and abide by the other licence terms. To view a copy of this licence, visit http://creativecommons.org/licenses/by/3.0/nz/ . 
Please note that n o governmental emblem, logo or Coat of Arms may be used in any way which infringes any provision of the Flags, 
Emblems, and Names Protection Act 1981 or would infringe such provision if the relevant use occurred within New Zealand. 
Attribution to the Minis try for Primary Industries should be in written form and not by reproduction of any such emblem, logo or Coat of 
Arms.  
Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  2 of 39 
 
 
 Contents  Page 
1 Purpose  3 
2 Background  3 
3 Definitions  3 
4 Importer Responsibilities  3 
5 Guidance  3 
5.1 Equivalence  3 
5.2 Incorporation of material by reference  4 
5.3 Exporting country systems and certification  4 
5.4 Diagnostic tests, vaccines and treatment  4 
5.5 Inspection and verification  5 
6 Specified Requirements for Identified Risk Organisms  6 
6.1 Model veterinary certificate Bovidae live  6 
6.2 Model veterinary certificate Bovidae semen  13 
6.3 Model veterinary certificate Giraffidae live  19 
6.4 Model veterinary certificate Giraffidae semen  25 
6.5 Model veterinary certificate Tragulidae live  30 
6.6 Model veterinary certificate Tragulidae semen  35 
Appendix 1 – Document History  39 
 
  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  3 of 39 
 
 
 1 Purpose  
(1) This guidance document has been issued to accompany the IHS: Zoo Bovidae, Giraffidae and 
Tragulidae (Live Animals and Semen) . This guidance document should be read in conjunction with that 
IHS.  
(2) This document includes:  
a) Countries with MPI -approved exporti ng systems to import  zoo Bovidae, Giraffidae a nd Tragulidae 
(live animals and semen ) into New Zealand.  
b) A model veterinary certificate.  
c) Links to n egotiated country specific veterinary certificates.  
2 Background  
(1) The IHS: Zoo Bovidae, Giraffidae and Tragulida e (Live Animals and Semen) , which this guidance 
document accompanies, contains generic import requirements. These are the rules to manage the 
biosecurity risk s of importing  zoo Bovidae, Giraffidae a nd Tragulidae (live animals and semen ) from 
Australi a, Canada, Europe, Japan, Singapore, South Africa, United Arab Emirates  and the United 
States  of America , and serve as the basis for country -to-country (bilateral) negotiations.  
(2) This guidance document contains model  veterinary certificate s, and once agreed, the country -specific  
veterinary certification for trade in  zoo Bovidae, Giraffidae a nd Tragulidae (live animals and semen ). 
These country -specific veterinary certificate s represent what will be certified prior  to exporting 
consignments of  zoo Bovidae, Giraffidae a nd Tragulidae (live animals and semen ) from the country 
specified.  
(3) General information about importing animal products can be found here:  
http://www.mpi.govt.nz/importing/food/   
3 Definitions  
(1) Refer to Schedule 2 of the IHS: Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen) . 
4 Importer Responsibilities  
(1) The costs to MPI in performing functions relating to the importation of  zoo Bovidae, Giraffidae a nd 
Tragulidae (live animals and semen ) will be recovered in accordance with the Biosecurity Act 1993 (the 
Act) and any regulations made under that Act. All costs involved with documentation, transport, 
storage and obtaining a biose curity clearance must be covered by the importer or agent.  
5 Guidance  
5.1 Equivalence  
(1) MPI may accept an alternative method, system or process that can be shown to achieve the 
biosecurity requirements of the IHS (i.e. equivalence).  
(2) MPI’s preference is that the exporting country’s Competent Authority makes equivalence requests. 
Equivalence requests can be lodged with animal.imports@mpi.govt.nz . 
(3) An import  permit may be required where sp ecific equivalence measures are approved by MPI. A n 
import permit serves as evidence of equivalence decisions and will be written as specific notes in the 
special conditions section of the permit.  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  4 of 39 
 
 
 (4) Apply online for an import permit at the following weblink:  https://animalplantimportpermit.mpi.govt.nz/  
5.2 Incorporation of material by reference  
(1) Incorporation by reference means that standards, guidelines or lists are incorporated into the IHS and 
they fo rm part of the requirements. This is done because technical documents are too large or 
impractical to include in the IHS.  
(2) Where the IHS states that section 142O(1) of the Act does not apply, this means that importers need to 
refer to the most recent version of any standards, guidelines or lists that are incorporated by reference 
in the IHS.  
5.3 Exporting country systems and certification  
5.3.1 Approval for exporting systems  
(1) MPI recommends Competent Authorities that request the approval of their exporting system s refer to 
Section 3 of the Code  titled Quality of Veterinary Services , to prepare evidence for MPI regarding 
capabilities and preferences of the exporting country’s Competent Authority.  
(2) The table below lists those exporting countries that meet the require ments set out in the IHS: Zoo 
Bovidae, Giraffidae and Tragulidae (Live Animals and Semen) . 
 
Countries with approved 
exporting systems  Biosecurity Plan Name  Date agreed  
   
5.3.2 Agreed country specific veterinary certificates  
(1) Requests from exporting countries to negotiate veterinary certification for the import of  zoo Bovidae, 
Giraffidae a nd Tragulidae (live animals and semen ) into New Zealand will be prioritised according to 
MPI resources available at the time of application.  
(2) A model veterinary c ertificate is provided in this guidance document and can be used by the 
Competent Authority as a reference for country -specific veterinary certificate negotiation.  
(3) All country -specific veterinary certificates agreed between an exporting country’s Competent  Authority 
and MPI are included in the table below:  
 
Country  Link to certificate  S27 CTO direction 
#  Date agreed  Date applicable 
for use  
     
(4) Country -specific veterinary certificates with equivalent measures will be recorded with a number 
relevant to a Chief Technical Officer (CTO) direction under section 27(1)d(iii) of the Act, to enable 
border staff to clear the goods and record the number in the MPI database.  
(5) Currently there are no country -specif ic veterinary certificates for  zoo Bovidae, Giraffidae a nd 
Tragulidae (live animals and semen ) imports into New Zealand.   
5.4 Diagnostic tests , vaccines and treatment  
(1) MPI lists all approved diagnostic  tests and vaccines in the MPI document: Approved Diagnostic Tests, 
Vaccines, Treatments and Post -Arrival Testing Laboratories for Animal Import Health Standards, MPI -
STD-TVTL . Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  5 of 39 
 
 
 (2) Where OIE -recommende d diagnostic tests and vaccines are listed, details can be found in the OIE 
Manual of Diagnostic Tests and Vaccines  found on the OIE website: http://w ww.oie.int/en/international -
standard -setting/terrestrial -manual/access -online/  
(3) The OIE Terrestrial Animal Health Code  chapter listing the prescribed and alternative diagnostic tests 
for OIE listed diseases is found on the OIE website: 
http://www.oie.int/index.php?id=169&L=0&htmfile=chapitr e_1.1.3.htm  
5.5 Inspection and verification  
(1) On arrival, all documentation accompanying the consignment will be verified by an inspector. The 
inspector may also inspect the consignment, or a sample of the consignment on arrival.  
(2) Inspectors are able to inspect a nd verify due to their authorised powers under the Act.  
(3) These requirements are independent of the IHS requirements.  
  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  6 of 39 
 
 
 6 Specified Requirements for Identified Risk Organisms  
6.1 Model veterinary certificate  Bovidae live  
(1) Below is a model veterinary certificate for trade in  live zoo Bovidae . This can be used by the exporting 
Competent Authority as a reference for country -specific veterinary certificate negotiation, but a 
certificate must be agreed between the exporting Competent Authority and MPI be fore trade can 
commence.  
 
Part 1: Details of dispatched consignment  1.1.  Consignor (Exporter):  
Name:  
Address:  
 1.2.  Certificate reference number:  
 
1.3.  Competent Authority:  
 
1.4.  Consignee (Importer):  
Name:  
Address:  
 
 
1.5.  Country of origin:  
ISO Code*  1.6.  Zone or compartment of origin:**  
 
1.7.  Country of destination :  
ISO Code*  1.8.  Zone o r compartment of destination:**  
1.9.  Place of origin:  
Name:  
Address:  
1.10.  Place of shipment:  1.11.  Date of departure:  
1.12.  Means of transport:  
 
    Aeroplane           Ship  
 
Identification:  
 1.13.  Expected border post:  
1.14.  CITES permit No(s):**  
1.15.  Description of commodity:  
 1.16.  Commodity Code (ISO Code*):  
1.17.  Total number of:  
1.18.  Temperature of commodities for transport:  
 1.19.  Total number of packages:  
1.20.  Identification of container/serial number:  
 1.21.  Type of packaging:  
1.22.  Identification of commodity:  Bovidae (live)  
Species (Scientific Name)  ID Number/Details  Breed/Category  Age Quantity  ID System  
      
      
      
 
* Optional   ** If referenced in Part 2  
  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  7 of 39 
 
 
 
Part 2:  Veterinary Information  Country:  Certificate reference number:  
I, the undersigned Official Veterinarian, certify that the animals described above satisfy the following requirements:   
 
Exporting zoo premises  
(1) Each animal has  been resident in one or more government -approved zoo premises, since birth or for at least 
twelve months prior to export, where the health of all bovids  was monitored so that the causes of incidents of 
disease and death were identified promptly . 
(2) The expor ting premises ha s been free of quarantine restrictions for the 90 days prior to the date of shipment . 
(3) The premises in which each animal for export resided is under permanent veterinary supervision, and a health 
monitoring programme was followed including necropsies, and microbiological and parasitological testing.  
Pre-export isolation   
(4) Each animal was:  
(a) Held in pre -export isolation for a minimum of 30 days prior to the date of shipment . 
(b) Isolated from other animals not of equivalent health status . 
(5) Individual health records were kept for each bovid  during the pre -export isolation period and any health problems 
during this time were reported to MPI.  
(6) The pre -export isolation premises:  
(a) Has been approved and supervised by an Official Veterinarian .  
(b) Has been free of grass and other pasture . 
(7) Bedding used during pre -export isolation was clean and free from evidence of contamination with ticks and seeds . 
(a) Prior to housing the animals, the premises w as thoroughly cleaned and sprayed with an acaricide.  
(i) Every 10  days:  
1. The bedding was removed ; and  
2. The premises was thoroughly cleaned and sprayed with an acaricide; or  
(b) Prior to housing the animals, the premises w as thoroughly cleaned and sprayed with a long lasting 
acaricide. Bedding was removed every 10 days.  
(8) While in pre -export isolation the animals were only fed feed showing no evidence of contamination with ticks and 
seeds.  
Inspection and transport  
(9)  If shipped by:  
(a) Air, each animal  will be shipped in accordance with the International Air Transport Association (IATA) Live 
Animal Regulations;  
(b) Sea, each animal  will be shipped in accordance with the Australian Marine Orders Part 43, Issue 6 .  
(10) The vehicle s in which the animals  will be tr ansported to the port of departure will be cleaned and disinfected prior 
to loading.  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  8 of 39 
 
 
 (11) The cargo space of the aircraft where the animals are to be transported will be sprayed prior to departure with an 
insecticidal spray approved by the Competent Authority o f the exporting country.  
(12) Each bovid  was identified and examined by an Official Veterinarian in the 24 hours prior to leaving the pre-export 
isolation premises for the port of departure.  
(13) Each bovid  was free from clinical evidence of infectious disease, exte rnal parasites, plant and seed 
contamination, and appeared fit for travel.  
Tests and treatments  (delete as appropriate)  
(14) Alcelaphine gammaherpesvirus 1 ( wildebeest -associated malignant catarrhal fever)  
(a) Connochaetes gnou  and Connochaetes taurinus  only: 
(i) During the 5 years prior to shipment no cases of wildebeest -associated malignant catarrhal fever  
were reported at the zoo(s) of origin; and     
(ii) During the 12 months prior to shipment no new Connochaetes have been introduced into the  
collection at the  zoo(s)  of origin.  
(15) Bovine alphaherpesvirus 1 ( BHV 1 ) 
(a) Each animal has resided since birth in a BHV 1(excluding BHV 1.2b) -free country and showed no clinical 
signs of infectious bovine rhinotracheitis/infectious pustular vulvovaginitis on the day of shipment; or  
(b) For the 6 months prior to shipment each animal resided at zoo premises where no clinical, epidemiological 
or other evidence of BHV 1 (excluding BHV 1.2b) occurred during the previous 12 months; and  
(i) In the 30 days prior to shipment whilst in pre-export isolation, blood samples from each animal 
were tested, using an MPI -approved test, for BHV 1 (excluding BHV 1.2b) twice with negative 
results at an interval of no less than 21 days; or  
(c) For the 6 months prior to shipment, each animal resided at z oo premises where no clinical, epidemiological 
or other evidence of BHV 1 (excluding BHV 1.2b) occurred during the previous 12 months. A screening 
programme was in place and included testing of all animals in the collection prior to the animals entering 
the collection. The diagnostic tests were able to identify infected or healthy carrier animals; and the 
collection remained a  herd during that time.  
(16) Bovine viral diarrhoea virus (BVDV) 2 and 3  
(a) Each animal has resided since birth in a BVDV 2 and BVDV 3 -free country and showed no clinical signs of 
BVD on the day of shipment; or  
(b) For the 6 months prior to shipment, each animal resided at zoo premises where no clinical, epidemiological 
or other evidence of BVDV 2 and BVD 3 occurred in the previous 12 months. A sc reening programme was 
in in place and included MPI -approved diagnostic testing of all animals in the collection prior to animals 
entering the collection. The diagnostic tests were able to identify persistently infected animals and the 
collection remained a  closed herd; or  
(c) During pre -export isolation each animal was subjected to the following three tests:  
(i) A whole blood sample was tested by RT -PCR with negative results; and  
(ii) A haired skin sample (ear notch or caudal tail fold) was tested by an antigen -captur e ELISA test 
with negative results; and  
(iii) A serum sample was tested by virus neutralisation with negative results.  
 
 Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  9 of 39 
 
 
 (17) Brucella abortus  and Brucella melitensis  (brucellosis)  
(a) Each animal has resided, since birth or for at least the 2 years prior to shipment, in a brucellosis ( B. 
abortus and B. melitensis )-free country and showed no clinical signs of brucellosis on the day of shipment; 
or 
(b) Each animal:  
(i) Was kept since birth or for the 12 months prior to export at zoo premises where no clinical, 
epidemiological or other evidence of brucellosis ( B. abortus and B. melitensis ) occurred in any 
species during the previous 2 years; and  
(ii) Showed no clinical signs of brucellosis on the day of shipment; and  
(iii) Was tested with an MPI -approved test for brucellosi s (B. abortus and B. melitensis ) with negative 
results, within the 30 days of export. For post -parturient females, the test was carried out at least 
30 days after giving birth.  
(18) Coxiella burnetii  (Q fever)  
(a) Each animal has resided since birth in a Q fever -free country and showed no clinical signs of Q fever on 
the day of shipment; or  
(b) Each animal:  
(i) Was resident for at least the 12 months prior to shipment at zoo premises where no clinical, 
epidemiological or other evidence of Q fever has occurred in any animal  species during the 
previous 2 years; and  
(ii) Was tested for Q fever within the 30 days prior to export, with an MPI -approved test with negative 
results.  
(19) Crimean Congo haemorrhagic fever orthonairovirus  
(a) Each animal has resided since birth in a Crimean Congo h aemorrhagic fever -free country and showed no 
clinical signs of Crimean Congo haemorrhagic fever on the day of shipment; or  
(b) For the 6 months prior to shipment, each animal resided at zoo premises where no cases of Crimean 
Congo haemorrhagic fever have been reported.  
(20) External parasites  
(a) During pre-export isolation each animal was treated twice, at least 14 days apart, with an 
insecticide/acaricide solution effective against ticks , mites , lice, and fleas .  
Name of ectoparasiticide: .............................................................................................................  
Active ingredient(s): ....................................................................................................... ...............  
Dose rate: .................................................................................................................. ...................  
Date of first treatment: ………................................................................................... .........................  
Date of second treatment: ………................................................................................................ ............  
(21) Foot and mouth disease (FMD) virus  
(a) Each animal has resided since birth in a country that is officially free from FMD in accordance with the 
Code and showed no clinical signs of FMD on the day of shipment; or  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  10 of 39 
 
 
 (b) Each animal has resided since birth or for at least the 6 months prior to export in a n FMD -free country in 
accordance with the Code or an MP I-approved FMD -free zone and showed no clinical signs of FMD on the 
day of shipment . 
(22) Internal parasites  
(a) During pre-export isolation each animal was treated twice, at least 14 days apart, for nematodes, cestodes 
and trematodes.  
Name of endoparasiticide: ….. ...........................................................................................................  
Active ingredient(s): …………………............................................................................................  
Dose rate: ….............. ...................................................................................................................  
Date of first treatment: .................................................................................................... ............... ... 
Date of second treatment: ......................................................................................................................  
(23) Lumpy skin disease  (LSD)  virus  
(a) Each animal has resided since birth or at least the three months prior to export in a n LSD-free country an d 
showed no clinical signs of LSD on the day of shipment; or  
(b) For the 6 months prior to shipment, each animal was continuously resident in a country where no clinical, 
epidemiological or other evidence of LSD occurred during the previous 3 years, where the disease is 
compulsorily notifiable , and where vaccination against LSDV has not occurred in the previous 3 years; and  
(i) Each animal showed no clinical signs of LSD during pre -export isolation, and has not been 
vaccinated against capripoxviruses in the previous 3 years; or  
(c) For the 6 months prior to shipment each animal resided at zoo premises where no case of LSD occurred 
during that period; and  
(i) During pre -export isolation e ach animal was subjected to an MPI -approved test with negative 
results ; and showe d no clinical signs of LSD on the day of shipment.  
(24) Mycobacterium bovis  (bovine tuberculosis)  
(a) Each animal has reside d since birth in a Mycobacterium bovis -free country and showed no clinical signs of 
bovine tuberculosis on the day of shipment; or  
(b) For the 12  months prior to shipment, each animal resided at zoo premises where no clinical, 
epidemiological or other evidence of Mycobacterium bovis  has occurred in the previous 5 years. During 
this time the animals were  protected from contact with any reservoir of Mycobacterium bovis  and showed 
no clinical signs of bovine tuberculosis on the day of shipment; or  
(c) During pre -export isolation e ach animal was subjected to MPI -approved testing for Mycobacterium bovis  
with negative results.  
(25) Mycoplasma capricolum  subsp. capripneumoniae  (contagious caprine pleuropneumonia)  
(a) Each animal has resided since birth in a contagious caprine pleuropneumonia -free country and showed no 
clinical signs of contagious caprine pleuropneumonia on the day of shipment; or  
(b) Each animal was kept in  pre-export isolation for at least 45 days immediately prior to shipment and 
showed no clinical signs of contagious caprine pleuropneumonia on the day of shipment.  
 
 Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  11 of 39 
 
 
 (26) Pasteurella multocida  (haemorrhagic septicaemia)  
(a) Each animal has resided since birth or for at least the 6 months prior to shipment in a Pasteurella 
multocida (B:2 and E:2) -free country and showed no clinical signs of haemorrhagic septicaemia on the day 
of shipment; or  
(b) Each animal was resident for at least the 12 months prior to shipment at zoo premises where no clinical, 
epidemiological or other evidence of Pasteurella multocida  (B:2 and E:2) occurred during the previous 12 
months and where animals are vaccinated agains t Pasteurella multocida  (B:2 and E:2) with an               
MPI-approved vaccine.  
(27) Peste des petits ruminants virus (PPRV)  
(a) Each animal has reside d since birth in a peste des petits ruminants -free country and showed no clinical 
signs of peste des petits rumi nants on the day of shipment; or  
(b) Each animal was subjected to an MPI -approved test for peste des petits ruminants within the 21 days prior 
to shipment with negative results and showed no clinical signs of peste des petits ruminants during pre -
export isolat ion. 
(28) Rabies  
(a) Each animal has resided since birth or for at least 6 months in a rabies -free county and showed no clinical 
signs of rabies on the day of shipment; or  
(b) For the 6 months prior to shipment each animal was kept at zoo premises where separation fro m 
susceptible animals was maintained and where there was no case of rabies for at least 12 months prior to 
shipment; and  
(i) Showed no clinical signs of rabies on the day of shipment.  
(29) Rift Valley fever (RVF) phlebovirus   
(a) Each animal has been resident since birth or for at least 14 days prior to shipment in a n RVF-free country 
and showed no clinical signs of RVF on the day of shipment; or  
(b) Each animal:  
(i) Showed no clinical signs of RVF during pre -export isolation and on the day of shipment; and  
(ii) Does not o riginate from an area of the epizootic; and  
(iii) Was held at least 14 days prior to export in vector protected pre -export isolation. The premises 
were  located in an area of demonstrated low vector activity.  
(30) Trypanosoma  spp. (surra and tsetse fly associated trypanosomosis)  
(a) Each animal has resided since birth in surra and tsetse fly associated trypanosomosis -free countries and 
showed no clinical signs of trypanosomosis on the day of shipment; or  
(b) Each animal:  
(i) Was resident, for at least 6 months prior  to shipment, at zoo premises where no clinical, 
epidemiological or other evidence of surra or tsetse fly associated trypanosomosis has occurred in 
any animal species in the previous 2 years; and  
(ii) During the pre -export isolation, a blood sample was drawn fr om a peripheral vein of the animals 
and tested for Trypanosoma  spp. using the haematocrit centrifuge technique, and a card 
agglutination test, with negative results.  
 Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  12 of 39 
 
 
  Official Veterinarian  
Name:  
Address:  
Email:  
  
Signature:   
Date:  
 
  
Official Veterinarian signature, 
Official stamp and date  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  13 of 39 
 
 
 6.2 Model veterinary certificate Bovidae se men 
(1) Below is a model veterinary certificate for trade in  Bovidae  semen . This model meets the requirements 
of the IHS.   This can be used by the exporting Competent Authority as a reference for country -specific 
veterinary certificate negotiation, but a certificate must be agreed between the exporting Competent 
Authority and MPI before trade can commence.  
 
 
Part 1: Details of dispatched consignment  1.1.  Consignor (Exporter):  
Name:  
Address:  
 1.2.  Certificate reference number:  
 
1.3.  Competent Authority:  
 
1.4.  Consignee (Importer):  
Name:  
Address:  
 
 
1.5.  Country of origin:  
ISO Code*  1.6.  Zone or compartment of origin:**  
 
1.7.  Country of destination :  
ISO Code*  1.8.  Zone o r compartment of destination:**  
1.9.  Place of origin:  
Name:  
Address:  
1.10.  Place of shipment:  1.11.  Date of departure:  
1.12.  Means of transport:  
 
    Aeroplane           Ship  
 
Identification:  
 1.13.  Expected border post:  
1.14.  CITES permit No(s):**  
1.15.  Description of commodity:  
 1.16.  Commodity Code (ISO Code*):  
1.17.  Total number of:  
1.18.  Temperature of commodities for transport:  
 1.19.  Total number of packages:  
1.20.  Identification of container/serial number:  
 1.21.  Type of packaging:  
1.22.  Identification of commodity:  Bovidae (semen)  
Species (Scientific Name)  ID Number/Details  Breed/Category  Age Quantity  ID System  
      
      
      
 
* Optional ** If referenced in Part 2  
  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  14 of 39 
 
 
 
Part 2:  Veterinary Information  Country:  Certificate reference number:  
I, the undersigned Official Veterinarian, certify that the semen  described above satisf ies the following requirements:   
 
Semen donor requirements  
(1) The donor males were  resident in an approved, licensed or registered zoo or wildlife park since birth or for at least 
the 12 months before semen collection . 
(2) The donor males were not under quarantine restriction for the collection period or the 90 days immediately prior 
collect ion. 
(3) The zoo or wildlife par k in which the donor males have been resident was under permanent veterinary 
supervision, and a health monitoring programme was followed including necropsies, and microbiological and 
parasitology testing.  
(4) The donor males were  free from clinical evidence of infectious disease transmissible in semen on the day of 
semen collection and for the 30 days immediately after.  
Semen collection, processing, storage,  and transport requirements  
(5) Personnel collecting and processing semen were  trained in, and practice d proper disinfection procedures and 
hygiene techniques.  
(6) All equipment and working surfaces likely to come into contact with semen for export have been appropriately 
cleaned and disinfected.  
(7) All semen straws, ampoules or containers  were identified with the donor animals and the date of collection.  
(8) All products of animal origin, other than egg yolk, used in collection, processing and storage of the semen were 
sterile preparations or were screened for adventitious viruses with negativ e results.  
(9) Any cryogenic or cooling agent used in the freezing process, storage, and transport was not used previously in 
association with any other product of animal origin.  
(10) The collection and transport containers are new or disinfected, and free of conta mination.  
(11) The semen was stored in a secure area prior to export . 
(12) The transport container in which the semen is transported to New Zealand was sealed , by either the registered 
veterinarian supervising the collection or  an Official Veterinarian, using tamper -evident seals.   
Seal number __________________________________________  
Tests and treatments (delete as appropriate ) 
(13) Bovine alphaherpesvirus 1 (BHV 1)  
(a) Each donor male has been resident since birth in a BHV 1(excluding BHV 1.2b) -free country and showed 
no clinical signs of infectious bovine rhinotracheitis/infectious pustular vulvovaginitis on the day of semen 
collection; or  
(b) The semen was tested by a virus isolation or real -time RT -PCR for BHV 1 (excluding BHV 1.2b), with 
negative results; or  
(c) Each donor male was held in isolation during the period of collection and for the 30 days following 
collection; and  
(i) Was subjected to an MPI -approved test for BHV 1 (excluding BHV 1.2b) on a blood sample taken 
at least 21 days after collection of the semen , with negative results; or  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  15 of 39 
 
 
 (d) For the 6 months prior to semen collection, each donor male resided at a zoo premise s where no clinical, 
epidemiological or other evidence of BHV 1 (excluding BHV 1.2b) occurred during the previous 12 months. 
A screening programme was in place and include d MPI-approved testing of all animals in the collection 
prior to the animals entering the collection. The diagnostic tests were  able to identify infected or healthy 
carrier animals; and the collection was a closed herd during that time.  
(14) Bovine viral diarrhoea virus (BVDV) 2 and BVDV 3  
(a) Each donor male has been resident since birth in a BVDV 2 and BVDV 3 -free country and showed no 
clinical signs of BVD on the day of semen collection; or  
(b) For the 6 months prior to shipment, each donor male resided at zoo premises where no clinical, 
epidemiological or other evidence of BVDV 2 and BVD 3 occurred i n the previous 12 months. A screening 
programme was in place and include d MPI-approved diagnostic testing of all animals in the collection prior 
to donor males entering the collection. The diagnostic tests were  able to identify infected and persistently 
infected animals and the collection was a closed herd; or  
(c) The semen was tested by a virus isolation or real -time RT -PCR for BVDV; or  
(d) Each donor male was tested by the following protocols during semen collection:  
(i) A whole blood sample from the donor animals w as tested by RT -PCR. The test result was negative 
for BVDV; and  
(ii) A haired skin sampled (ear notch or caudal tail fold) from the animal(s) was tested by an antigen -
capture ELISA test. The test result was negative; and  
(iii) A serum sample from the animal was test ed by virus neutralisation. The test result was negative.  
(15) Brucella abortus  and Brucella melitensis  (brucellosis)  
(a) Each donor male was resident since birth or for at least the 2 years prior to semen collection, in a 
brucellosis ( B. abortus and B. melitensis )-free country and showed no clinical signs of brucellosis on the 
day of collection; or  
(b) Each donor male:  
(i) Was kept since birth or for the 12 months prior to semen collection at a zoo premise s where no 
clinical, epidemiological or other evidence of brucellosis ( B. abortus and B. melitensis ) has 
occurred in any species during the previous 2 years; and  
(ii) Showed no clinical signs of brucellosis on the day of semen collection; and  
(iii) Was subjected to an MPI -approved test for brucellosis ( B. abortus and B. melitensis ) within the 30 
days after collection with negative results; or  
(iv) A straw from each semen sample was tested for brucellosis ( B. abortus and B. melitensis ) with an 
MPI-approved tes t with negative results.  
(16) Coxiella burnetii (Q fever)  
(a) Each donor male has been resident since birth in a Q fever -free country and showed no clinical signs of Q 
fever on the day of collection; or  
(b) Each donor male:  
(i) Was resident for at least the 12 months prior  to collection at a zoo premise s where no clinical, 
epidemiological or other evidence of Q fever occurred in any animal species during the previous 2 
years; and  
(ii) Was tested for Q fever with an MPI -approved test with negative results within 30 days following  
semen collection, or  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  16 of 39 
 
 
 (iii) A straw of semen from each collection batch was tested for Q fever with a microagglutination, 
indirect immunofluorescence assay or PCR test with negative results.  
(17) Foot and mouth disease  (FMD) virus  
(a) Each donor male has been resident s ince birth in a country that is officially free from FMD in accordance 
with the Code and showed no clinical signs of FMD on the day of semen collection; or  
(b) Each donor male:  
(i) Showed no clinical signs of FMD on the day of semen collection and for the followin g 30 days; and  
(ii) Was resident for at least the 6 months prior to collection in an FMD -free country in accordance with 
the Code where vaccination is not practised or in an FMD -free zone.; or  
(c) Each donor male:  
(i) Showed no clinical signs of FMD on the day of semen collection and for the following 30 days; and  
(ii) Was resident since birth or for at least 6 months at a facility where no animal had been added in 
the 30 days before semen collection and no FMD had occurred  within a 10 -kilometre radius of the 
facility for the 30 days before and after collection; and  
(iii) A straw from each semen sample was subjected to an MPI -approved test for FMDV with negative 
results and the semen was stored in the country of origin for a perio d of at least one month 
following collection. During this period, no animal at the facility where the donor males were kept 
showed any sign of FMD.  
(18) Lumpy skin disease (LSD)  virus  
(a) Each donor male has been resident since birth or for at least the 28 days pri or to the collection of semen in 
an LSD -free country and showed no clinical signs of LSD on the day of collection; or  
(b) For the 6 months prior to semen collection each donor male was continuously resident in a country where 
no clinical, epidemiological or ot her evidence of LSD occurred during the previous 3 years, where LSD is 
compulsorily notifiable and where vaccination against LSDV has not occurred in the previous 3 years; or  
(c) Each donor male:  
(i) Was kept for the 60 days prior to collection in a zoo where no case of LSD occurred during that 
period; and  
(ii) Showed no clinical sign of LSD on the day of collection and the following 28 days; and  
(iii) Was subjected to a serological test to detect antibodies specific to LSDV, with negative results, at 
least every 28 days thr oughout the collection period and one test 21 days after the final collection 
for this consignment; and  
(iv) Was subjected to agent detection by PCR conducted on blood samples collected at 
commencement and conclusion of, and at least every 28 days during, semen  collection, with 
negative results; and  
(v) A straw from each semen sample to be exported was subjected to LSDV detection by PCR.  
 
 
 
 Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  17 of 39 
 
 
 (19) Mycobacterium bovis  (bovine tuberculosis)  
(a) Each donor male has been resident since birth in a Mycobacterium bovis -free country and showed no 
clinical signs of bovine tuberculosis on the day of semen collection; or  
(b) For the 12 months prior to semen collection, each donor male resided on a premise s where no clinical, 
epidemiological or other evidence of Mycobacterium bovis  has occurred during the previous 3 years. 
During this time the donor males have been protected from contact with any reservoir of Mycobacterium 
bovis  and showed no clinica l signs of bovine tuberculosis on the day of semen collection; or  
(c) Each donor male was subjected to MPI -approved testing for Mycobacterium bovis  with negative results; or  
(d) At least 3 straws from each collection batch of semen from each donor animals were tes ted via PCR, with 
negative results.  
(20) Peste des petits ruminants virus (PPRV)  
(a) Each donor male has been resident since birth in a peste des petits ruminants -free country and showed no 
clinical signs of peste des petits ruminants on the day of semen collection ; or 
(b) Each donor male:  
(i) Was kept, for at least 21 days prior to collection, at a zoo premise s where no case of peste des 
petits ruminants was reported during that period, which was not situated in a peste des petits 
ruminants infected zone and to which no an imals had been added during the 21 days prior to 
collection; and  
(ii) Showed no clinical signs of peste des petits ruminants for at least 21 days prior to collection of 
semen and during the following 21 days; and  
(iii) Was tested with an MPI -approved test for peste d es petits ruminants with negative results, at least 
21 days prior to collection of semen; or  
(iv) A straw of semen from each collection batch was tested for peste des petits ruminants with an 
MPI-approved test and was negative . 
(21) Rift Valley fever (RVF) phlebovir us   
(a) Each donor male has been resident since birth or for at least the14 days prior to semen collection in a n       
RVF-free country and showed no clinical signs of RVF on the day of collection; or  
(b) Each donor male:  
(i) Showed no clinicals signs of RVF within the period from 14 days prior to and 14 days following 
collection of the semen; and  
(ii) Was tested via paired serum samples with an MPI -approved test. Results demonstrated that 
seroconversion did not occur between semen  collection and 14 days after.  
 
 Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  18 of 39 
 
 
  Official Veterinarian  
Name:  
Address:  
Email:  
  
Signature:   
Date:  
 
  
Official Veterinarian signature, 
Official stamp and date  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  19 of 39 
 
 
 6.3 Model veterinary certificate Giraffidae  live 
(1) Below is a model veterinary certificate for trade in live Giraffidae . This can be used by the exporting 
Competent Authority as a reference for country -specific veterinary certificate negotiation, but a 
certificate must be agreed between the exporting Com petent Authority and MPI before trade can 
commence.  
 
Part 1: Details of dispatched consignment  1.1.  Consignor (Exporter):  
Name:  
Address:  
 1.2.  Certificate reference number:  
 
1.3.  Competent Authority:  
 
1.4.  Consignee (Importer):  
Name:  
Address:  
 
 
1.5.  Country of origin:  
ISO Code*  1.6.  Zone or compartment of origin:**  
 
1.7.  Country of destination :  
ISO Code*  1.8.  Zone o r compartment of destination:**  
1.9.  Place of origin:  
Name:  
Address:  
1.10.  Place of shipment:  1.11.  Date of departure:  
1.12.  Means of transport:  
 
    Aeroplane           Ship  
 
Identification:  
 1.13.  Expected border post:  
1.14.  CITES permit No(s):**  
1.15.  Description of commodity:  
 1.16.  Commodity Code (ISO Code*):  
1.17.  Total number of:  
1.18.  Temperature of commodities for transport:  
 1.19.  Total number of packages:  
1.20.  Identification of container/serial number:  
 1.21.  Type of packaging:  
1.22.  Identification of commodity:  Giraffidae  (live)  
Species (Scientific Name)  ID Number/Details  Breed/Category  Age Quantity  ID System  
      
      
      
 
* Optional  ** If referenced in Part 2  
 Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  20 of 39 
 
 
 
Part 2:  Veterinary Information  Country:  Certificate reference number:  
I, the undersigned Official Veterinarian, certify that the animals described above satisfy the following requirements:   
 
Exporting zoo premises  
(1) Each animal has  been resident in one or more government -approved zoo premises, since birth or for at least 
twelve months prior to export, where the health of all giraffid s was monitored so that the causes of incidents of 
disease and death were identified promptly . 
(2) The exporting premises ha s been free of quarantine restrictions for the 90 days prior to the date of shipment.  
(3) The premises in which each animal for export resided is under permanent veterinary supervision, and a health 
monitoring programme was followed includin g necropsies, and microbiological and parasitological testing.  
Pre-export isolation  
(4) Each animal was : 
(a) Held in pre -export isolation for a minimum of 30 days prior to the date of shipment  
(b) Isolated from other animals not of equivalent health status . 
(5) Individual health records were kept for each giraffid  during the pre -export isolation period and any health 
problems during this time were reported to MPI.  
(6) The pre -export isolation premises:  
(a) Has been approved and supervised by an Official Veterinarian  
(b) Has been free of grass and other pasture . 
(7) Bedding used during pre -export isolation was clean and free from evidence of contamination with ticks and seeds . 
(a) Prior to housing the animals, the premises w as thoroughly cleaned and sprayed with an acaricide.  
(i) Every 10 days:  
1. The bedding was removed ; and  
2. The premises was thoroughly cleaned and sprayed with an acaricide; or  
(b) Prior to housing the animals, the premises w as thoroughly cleaned and sprayed with a long lasting 
acaricide. Bedding was removed every 10 days . 
(8) While in pre -export isolation the animals were only fed feed showing no evidence of contamination with ticks and 
seeds.  
Inspection and transport  
(9)  If shipped by:  
(a) Air, each  animal  will be shipped in accordance with the International Air Transport Associati on (IATA) Live 
Animal Regulations;  
(b) Sea, each animal  will be shipped in accordance with the Australian Marine Orders Part 43, Issue 6 .  
(10) The vehicles in which the animals will be transported to the port of departure will be cleaned and disinfected prior 
to loading.  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  21 of 39 
 
 
 (11) The cargo space of the aircraft where the animals are to be transported will be sprayed prior to departure with an 
insecticidal spray approved by the Competent Authority of the exporting country.  
(12) Each giraffid was  identified and examined by an Offi cial Veterinarian in the 24 hours prior to leaving the pre-
export isolation premises for the port of departure.  
(13) Each giraffid  was free from clinical evidence of infectious disease, external parasites, plant and seed 
contamination, and appeared fit for trav el. 
Tests and treatments (delete as appropriate)  
(14) Bovine alphaherpesvirus 1 ( BHV 1 ) 
(a) Each animal has resided since birth in a BHV 1(excluding BHV 1.2b) -free country and showed no clinical 
signs of infectious bovine rhinotracheitis/infectious pustular vulvovaginitis on the day of shipment; or  
(b) For the 6 months prior to shipment each animal resided at zoo premises where no clinical, epidemiological 
or other evidence of BHV 1 (excluding BHV 1.2b) occurred during the prev ious 12 months; and  
(i) In the 30 days prior to shipment whilst in pre -export isolation, blood samples from each animal 
were tested, using an MPI -approved test, for BHV 1 (excluding BHV 1.2b) twice with negative 
results at an interval of no less than 21 days;  or 
(c) For the 6 months prior to shipment, each animal resided at zoo premises where no clinical, epidemiological 
or other evidence of BHV 1 (excluding BHV 1.2b) occurred during the previous 12 months. A screening 
programme was in place and included testing o f all animals in the collection prior to the animals entering 
the collection. The diagnostic tests were able to identify infected or healthy carrier animals; and the 
collection remained a herd during that time.  
(15) Brucella abortus  and Brucella melitensis  (brucellosis)  
(a) Each animal has resided, since birth or for at least the 2 years prior to shipment, in a brucellosis ( B. 
abortus  and B. melitensis )-free country and showed no clinical signs of brucellosis on the day of shipment; 
or 
(b) Each animal:  
(i) Was kept since birth or for the 12 months prior to export at zoo premises where no clinical, 
epidemiological or other evidence of brucellosis ( B. abortus  and B. melitensis ) occurred in any 
species during the previous 2 years; and  
(ii) Showed no clinical signs of brucellosis on the day of shipment; and  
(iii) Was tested with an MPI -approved test for brucellosis ( B. abortus  and B. melitensis ) with negative 
results, within the 30 days of export. For post -parturient females, the test was carried out at least 
30 days after gi ving birth.  
(16) Crimean Congo haemorrhagic fever orthonairovirus  
(a) Each animal has resided since birth in a Crimean Congo haemorrhagic fever -free country and showed no 
clinical signs of Crimean Congo haemorrhagic fever on the day of shipment; or  
(b) For the 6 month s prior to shipment, each animal resided at zoo premises where no cases of Crimean 
Congo haemorrhagic fever have been reported.  
(17) External parasites  
(a) During pre-export isolation each animal was treated twice, at least 14 days apart, with an 
insecticide/acaric ide solution effective against ticks , mites , lice, and fleas.  
Name of ectoparasiticide: ................................................................................................... ..........  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  22 of 39 
 
 
 Active ingredient(s): ................................... ...................................................................................  
Dose rate: .................................................................................................................. ...................  
Date of first treatment: …… …............................................................................................................  
Date of second treatment: ………................................................................................................ ............  
(18) Foot and  mouth disease (FMD) virus  
(a) Each animal has resided since birth in a country that is officially free from FMD in accordance with the 
Code and showed no clinical signs of FMD on the day of shipment; or  
(b) Each animal has resided since birth or for at least the 6 months prior to export in a n FMD -free country in 
accordance with the Code or an MPI -approved FMD -free zone and showed no clinical signs of FMD on the 
day of shipment . 
(19) Internal parasites  
(a) During pre-export isolation each animal was treated twice, at least 14 days apart, for nematodes, cestodes 
and trematodes.  
Name of endoparasiticide: ….............................................................................................................  
Active ingredient(s): …………………............................................................................................  
Dose rate: …........... ......................................................................................................................  
Date of first treatment: .................................................................................................... ............ ...... 
Date of second treatment: ................................................................................................... ...................  
(20) Lumpy skin disease  (LSD)  virus  
(a) Each animal has resided since birth or at least the three months prior to  export in a n LSD-free country and 
showed no clinical signs of LSD on the day of shipment; or  
(b) For the 6 months prior to shipment, each animal was continuously resident in a country where no clinical, 
epidemiological or other evidence of LSD occurred during  the previous 3 years, where the disease is 
compulsorily notifiable and where vaccination against LSDV has not occurred in the previous 3 years; and  
(i) Each animal showed no clinical signs of LSD during pre -export isolation, and has not been 
vaccinated agains t capripoxviruses in the previous 3 years; or  
(c) For the 6 months prior to shipment each animal resided at zoo premises where no case of LSD occurred 
during that period; and  
(i) During pre -export isolation each animal was subjected to an MPI -approved test with ne gative 
results; and showed no clinical signs of LSD on the day of shipment.  
(21) Mycobacterium bovis  (bovine tuberculosis)  
(a) Each animal has resided since birth in a Mycobacterium bovis -free country and showed no clinical signs of 
bovine tuberculosis on the day o f shipment; or  
(b) For the 12 months prior to shipment, each animal resided at zoo premises where no clinical, 
epidemiological or other evidence of Mycobacterium bovis  has occurred in the previous 5 years. During 
this time the animals were protected from conta ct with any reservoir of Mycobacterium bovis  and showed 
no clinical signs of bovine tuberculosis on the day of shipment; or  
(c) During pre -export isolation each animal was subjected to MPI -approved testing for Mycobacterium bovis  
with negative results.  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  23 of 39 
 
 
 (22) Pasteur ella multocida  (haemorrhagic septicaemia)  
(a) Each animal has resided since birth or for at least the 6 months prior to shipment in a Pasteurella 
multocida (B:2 and E:2) -free country and showed no clinical signs of haemorrhagic septicaemia on the day 
of shipment; or  
(b) Each animal was resident for at least the 12 months prior to shipment, at zoo premises where no clinical, 
epidemiological or other evidence of Pasteurella multocida  (B:2 and E:2) occurred during the previous 12 
months and where animals are vac cinated against Pasteurella multocida  (B:2 and E:2) with an               
MPI-approved vaccine.  
(23) Peste des petits ruminants virus (PPRV)  
(a) Each animal has reside d since birth in a peste des petits ruminants -free country and showed no clinical 
signs of peste des petits ruminants on the day of shipment; or  
(b) Each animal was subjected to an MPI -approved test for peste des petits ruminants within the 21 days prior 
to shipment with negative results and showed no clinical signs of peste des petits ruminants dur ing pre -
export isolation.  
(24) Rabies  
(a) Each animal has resided since birth or for at least 6 months in a rabies -free county and showed no clinical 
signs of rabies on the day of shipment; or  
(b) For the 6 months prior to shipment each animal was kept at zoo premises  where separation from 
susceptible animals was maintained and where there was no case of rabies for at least 12 months prior to 
shipment; and  
(i) Showed no clinical signs of rabies on the day of shipment.  
(25) Rift Valley fever (RVF) phlebovirus   
(a) Each animal has b een resident since birth or for at least 14 days prior to shipment in a n RVF-free country 
and showed no clinical signs of RVF on the day of shipment; or  
(b) Each animal:  
(i) Showed no clinical signs of RVF during pre -export isolation and on the day of shipment; a nd 
(ii) Does not originate from an area of the epizootic; and  
(iii) Was held at least 14 days prior to export in vector protected pre -export isolation. The premises 
were located in an area of demonstrated low vector activity.  
(26) Trypanosoma  spp. (surra and tsetse fly as sociated trypanosomosis)  
(a) Each animal has resided since birth in surra and tsetse fly associated trypanosomosis -free countries  and 
showed no clinical signs of trypanosomosis on the day of shipment; or  
(b) Each animal:  
(i) Was resident, for at least 6 months prior to shipment, at zoo premises where no clinical, 
epidemiological or other evidence of surra or tsetse fly associated trypanosomosis has occurred in 
any animal species in the previous 2 years; and  
(ii) During the pre -export isolation, a blood sample was dra wn from a peripheral vein of the animals 
and tested for Trypanosoma  spp. using the haematocrit centrifuge technique, and a card 
agglutination test, with negative results.  
 Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  24 of 39 
 
 
  Official Veterinarian  
Name:  
Address:  
Email:  
  
Signature:   
Date:  
 
  
Official Veterinarian signature, 
Official stamp and date  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  25 of 39 
 
 
 6.4 Model veterinary certificate Giraffidae semen  
(1) Below is a model veterinary certificate for trade in Giraffidae  semen . This can be used by the exporting 
Competent Authority as a reference for country -specific veterinary certificate negotiation, but a 
certificate must be agreed between the exporting Competent Authority and MPI before trade can 
commence.  
 
Part 1: Details of dispatched consignment  1.1.  Consignor (Exporter):  
Name:  
Address:  
 1.2.  Certificate reference number:  
 
1.3.  Competent Authority:  
 
1.4.  Consignee (Importer):  
Name:  
Address:  
 
 
1.5.  Country of origin:  
ISO Code*  1.6.  Zone or compartment of origin:**  
 
1.7.  Country of destination :  
ISO Code*  1.8.  Zone o r compartment of destination:**  
1.9.  Place of origin:  
Name:  
Address:  
1.10.  Place of shipment:  1.11.  Date of departure:  
1.12.  Means of transport:  
 
    Aeroplane           Ship  
 
Identification:  
 1.13.  Expected border post:  
1.14.  CITES permit No(s):**  
1.15.  Description of commodity:  
 1.16.  Commodity Code (ISO Code*):  
1.17.  Total number of:  
1.18.  Temperature of commodities for transport:  
 1.19.  Total number of packages:  
1.20.  Identification of container/serial number:  
 1.21.  Type of packaging:  
1.22.  Identification of commodity:  Giraffidae ( semen ) 
Species (Scientific Name)  ID Number/Details  Breed/Category  Age Quantity  ID System  
      
      
      
 
* Optional  ** If referenced in Part 2  
  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  26 of 39 
 
 
 
Part 2:  Veterinary Information  Country:  Certificate reference number:  
I, the undersigned Official Veterinarian, certify that the  semen  described above satisf ies the following requirements:   
 
Semen donor requirements  
(1) The donor males were  resident in an approved, licensed or registered zoo or wildlife park since birth or for at least  
the 12 months before semen collection . 
(2) The donor males were not under quarantine restriction for the collection period or the 90 days immediately prior 
collection.  
(3) The zoo or wildlife par k in which the donor males have been resident was under permanent veterinary 
supervision, and a health monitoring programme was followed including necropsies, and microbiological and 
parasitology testing.  
(4) The donor males were  free from clinical evidence of infectious disease transmissible in semen on the  day of 
semen collection and for the 30 days immediately after.  
Semen collection, processing, storage, and transport requirements  
(5) Personnel collecting and processing semen was trained in, and practice d, proper disinfection procedures and 
hygiene techniques.  
(6) All equipment and working surfaces likely to come into contact with semen for export have been appropriately 
cleaned and disinfected.  
(7) All semen straws, ampoules or containers were identified with the donor animals and the date of collection.  
(8) All products of animal origin, other than egg yolk, used in collection, processing and storage of the semen were 
sterile preparations or were screened for adventitious viruses with negative results.  
(9) Any cryogenic or cooling agent used in the freezing process , storage, and transport was not used previously in 
association with any other product of animal origin.  
(10) The collection and transport containers are new or disinfected, and free of contamination.  
(11) The semen was stored in a secure area prior to export . 
(12) The t ransport container in which the semen is transported to New Zealand was sealed, by either the registered 
veterinarian supervising the collection or an Official Veterinarian, using tamper -evident seals.  
Seal number _________________________________________ _ 
Tests and treatments (delete as appropriate ) 
(13) Bovine alphaherpesvirus 1 (BHV 1)  
(a) Each donor male has been resident since birth in a BHV 1(excluding BHV 1.2b) -free country  and showed 
no clinical signs of infectious bovine rhinotracheitis/infectious pustular  vulvovaginitis on the day of semen 
collection; or  
(b) The semen was tested by a virus isolation or real -time RT -PCR for BHV 1 (excluding BHV 1.2b), with 
negative results; or  
(c) Each donor male was held in isolation during the period of collection and for the 30 days following 
collection; and  
(i) Was subjected to an MPI -approved test for BHV 1 (excluding BHV 1.2b) on a blood sample taken 
at least 21 days after collection of the semen , with negative results; or  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  27 of 39 
 
 
 (d) For the 6 months prior to semen collection, each donor male resided at a zoo premise s where no clinical, 
epidemiological or other evidence of BHV 1 (excluding BHV 1.2b) occurred during the previous 12 months. 
A screening program me was in place and include d MPI-approved testing of all animals in the collection 
prior to the animals entering the collection. The diagnostic tests were  able to identify infected or healthy 
carrier animals; and the collection was a closed herd during tha t time.  
(14) Brucella abortus  and Brucella melitensis  (brucellosis)  
(a) Each donor male was resident since birth or for at least the 2 years prior to semen collection, in a 
brucellosis ( B. abortus and B. melitensis )-free country and showed no clinical signs of brucellosis on the 
day of collection; or  
(b) Each donor male:  
(i) Was kept since birth or for the 12 months prior to semen collection at a zoo premise s where no 
clinical, epidemiological or other evidence of brucellosis ( B. abortus and B. melitensis ) has 
occurred in any species during the previous 2 years; and  
(ii) Showed no clinical signs of brucellosis on the day of semen collection; and  
(iii) Was subjected to an MPI -approved test for brucellosis ( B. abortus and B. melitensis ) within the 30 
days after collection with negat ive results; or  
(iv) A straw from each semen sample was tested for brucellosis ( B. abortus and B. melitensis ) with an 
MPI-approved test with negative results . 
(15) Foot and mouth disease (FMD) virus  
(a) Each donor male has been resident since birth in a country that is officially free from FMD in accordance 
with the Code and showed no clinical signs of FMD on the day of semen collection; or  
(b) Each donor male:  
(i) Showed no clinical signs of FMD on the day of semen collection and for the following 30 days; and  
(ii) Was resident for at least the 6 months prior to collection in an FMD -free country in accordance with 
the Code where vaccination is not practised or in an FMD -free zone; or  
(c) Each donor male:  
(i) Showed no clinical signs of FMD on the day of semen collection and for the following  30 days; and  
(ii) Was resident since birth or for at least 6 months at a facility where no animal had been added in 
the 30 days before semen collection and no FMD had occurred within a 10 -kilometre radius of the 
facility for the 30 days before and after colle ction; and  
(iii) A straw from each semen sample was subjected to an MPI -approved test for FMDV with negative 
results and the semen was stored in the country of origin for a period of at least one month 
following collection. During this period, no animal at the f acility where the donor males were kept 
showed any sign of FMD.  
(16) Lumpy skin disease (LSD)  virus  
(a) Each donor male has been resident since birth or for at least the 28 days prior to the collection of semen in 
an LSD -free country and showed no clinical signs of LSD on the day of collection; or  
(b) For the 6 months prior to semen collection each donor male was continuously resident in a country where 
no clinical, epidemiological or other evidence of LSD occurred during the previous 3 years, where LSD is 
compu lsorily notifiable and where vaccination against LSDV has not occurred in the previous 3 years; or  
(c) Each donor male:  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  28 of 39 
 
 
 (i) Was kept for the 60 days prior to collection at a zoo  premises  where no case of LSD occurred 
during that period; and  
(ii) Showed no clinical sig n of LSD on the day of collection and the following 28 days; and  
(iii) Was subjected to a serological test to detect antibodies specific to LSDV, with negative results, at 
least every 28 days throughout the collection period and one test 21 days after the final collection 
for this consignment; and  
(iv) Was subjected to agent detection by PCR conducted on blood samples collected at 
commencement and conclusion of, and at least every 28 days during, semen collection, with 
negative results; and  
(v) A straw from each semen sam ple to be exported was subjected to LSDV detection by PCR.  
(17) Mycobacterium bovis  (bovine tuberculosis)  
(a) Each donor male has been resident since birth in a Mycobacterium bovis -free country and showed no 
clinical signs of bovine tuberculosis on the day of semen  collection; or  
(b) For the 12 months prior to semen collection, each donor male resided on a premise s where no clinical, 
epidemiological or other evidence of Mycobacterium bovis  has occurred during the previous 3 years. 
During this time the donor males have been protected from contact with any reservoir of Mycobacterium 
bovis and showed no clinical signs of bovine tuberculosis on the day of semen collection; or  
(c) Each donor male was subjected to MPI -approved testing for Mycobacterium bovis with negative results ; or 
(d) At least 3 straws from each collection batch of semen from each donor animals were tested via PCR, with 
negative results.  
(18) Peste des petits ruminants virus (PPRV)  
(a) Each donor male has been resident since birth in a peste des petits ruminants -free country and showed no 
clinical signs of peste des petits ruminants on the day of semen collection; or  
(b) Each donor male:  
(i) Was kept, for at least 21 days prior to collection, at a zoo premise s where no case of peste des 
petits ruminants was reported during tha t period, which was not situated in a peste des petits 
ruminants infected zone and to which no animals had been added during the 21 days prior to 
collection; and  
(ii) Showed no clinical signs of peste des petits ruminants for at least 21 days prior to collectio n of 
semen and during the following 21 days; and  
(iii) Was tested with an MPI -approved test for peste des petits ruminants with negative results, at least 
21 days prior to collection of semen; or  
(iv) A straw of semen from each collection batch was tested for peste des petits ruminants with an 
MPI-approved test and was negative.  
(19) Rift Valley fever (RVF) phlebovirus   
(a) Each donor male has been resident since birth or for at least the 14 days prior to semen collection in a n       
RVF-free country and showed no clin ical signs of RVF on the day of collection; or  
(b) Each donor male:  
(i) Showed no clinicals signs of RVF within the period from 14 days prior to and 14 days following 
collection of the semen; and  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  29 of 39 
 
 
 (ii) Was tested via paired serum samples with an MPI -approved test. Resu lts demonstrated that 
seroconversion did not occur between semen collection and 14 days after.  
 Official Veterinarian  
Name:  
Address:  
Email:  
  
Signature:   
Date:  
 
  
Official Veterinarian signature, 
Official stamp and date  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  30 of 39 
 
 
 6.5 Model veterinary certificate  Tragulidae  live 
(1) Below is a model veterinary certificate for trade in live Tragulidae . This can be used by the exporting 
Competent Authority as a reference for country -specific veterinary certificate negotiation, but a 
certificate must be agre ed between the exporting Competent Authority and MPI before trade can 
commence.  
 
Part 1: Details of dispatched consignment  1.1.  Consignor (Exporter):  
Name:  
Address:  
 1.2.  Certificate reference number:  
 
1.3.  Competent Authority:  
 
1.4.  Consignee (Importer):  
Name:  
Address:  
 
 
1.5.  Country of origin:  
ISO Code*  1.6.  Zone or compartment of origin:**  
 
1.7.  Country of destination :  
ISO Code*  1.8.  Zone o r compartment of destination:**  
1.9.  Place of origin:  
Name:  
Address:  
1.10.  Place of shipment:  1.11.  Date of departure:  
1.12.  Means of transport:  
 
    Aeroplane           Ship  
 
Identification:  
 1.13.  Expected border post:  
1.14.  CITES permit No(s):**  
1.15.  Description of commodity:  
 1.16.  Commodity Code (ISO Code*):  
1.17.  Total number of:  
1.18.  Temperature of commodities for transport:  
 1.19.  Total number of packages:  
1.20.  Identification of container/serial number:  
 1.21.  Type of packaging:  
1.22.  Identification of commodity:  Tragulidae  (live) 
Species (Scientific Name)  ID Number/Details  Breed/Category  Age Quantity  ID System  
      
      
      
 
* Optional  ** If referenced in Part 2  
  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  31 of 39 
 
 
 
Part 2:  Veterinary Information  Country:  Certificate reference number:  
I, the undersigned Official Veterinarian, certify that the animals described above satisf y the following requirements:   
 
Exporting zoo premises  
(1) Each animal has  been resident in one or more government -approved zoo premises, since birth or for at least 
twelve months prior to export, where the health of all  tragulid s was monitored so that the causes of incidents of 
disease and death were identified promptly . 
(2) The exporting premises ha s been free of quarantine restrictions for the 90 days prior to the date of shipment.  
(3) The premises in which each animal for export resided is under permanent veterinary supervision, and a health 
monitoring programme was followed in cluding necropsies, and microbiological and parasitological testing.  
Pre-export isolation  
(4) Each animal was : 
(a) Held in pre -export isolation for a minimum of 30 days prior to the date of shipment  
(b) Isolated from other animals not of equivalent health status . 
(5) Individual health records were kept for each tragulid  during the pre -export isolation period and any health 
problems during this time were reported to MPI.  
(6) The pre -export isolation premises:  
(a) Has been approved and supervised by an Official Veterinarian  
(b) Has been free of grass and other pasture . 
(7) Bedding used during pre -export isolation was clean and free from evidence of contamination with ticks and seeds  
(a) Prior to housing the animals, the premises w as thoroughly cleaned and sprayed with an acaricide.  
(i) Every 10  days:  
1. The bedding was removed ; and  
2. The premises was thoroughly cleaned and sprayed with an acaricide; or  
(b) Prior to housing the animals, the premises w as thoroughly cleaned and sprayed with a long lasting 
acaricide. Bedding was removed every 10 days.  
(8) While in pre -export isolation the animals were only fed feed showing no evidence of contamination with ticks and 
seeds.  
Inspection and transport  
(9)  If shipped by:  
(a) Air, each animal will be shipped in accordance with the International Air Transport Association (IATA) Live 
Animal Regulations;  
(b) Sea, each animal will be shipped in accordance with the Australian Marine Orders Part 43, Issue 6 . 
(10) The vehicles in which the animals will be transported to the port of departure will be cleaned and disinfected pr ior 
to loading.  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  32 of 39 
 
 
 (11) The cargo space of the aircraft where the animals are to be transported will be sprayed prior to departure with an 
insecticidal spray approved by the Competent Authority of the exporting country.  
(12) Each tragulid was identified and examined by  an Official Veterinarian in the 24 hours prior to leaving the pre-
export isolation premises for the port of departure.  
(13) Each tragulid was free from clinical evidence of infectious disease, external parasites, plant and seed 
contamination, and appeared fit for travel.  
Tests and treatments (delete as appropriate)  
(14) Bovine viral diarrhoea virus (BVDV) 2 and 3  
(a) Each animal has resided since birth in a BVDV 2 and BVDV 3 -free country and showed no clinical signs of 
BVD on the day of shipment; or  
(b) For the 6 months pri or to shipment, each animal resided at zoo premises where no clinical, epidemiological 
or other evidence of BVDV 2 and BVD 3 occurred in the previous 12 months. A screening programme was 
in in place and included MPI -approved diagnostic testing of all anima ls in the collection prior to animals 
entering the collection. The diagnostic tests were able to identify persistently infected animals and the 
collection remained a closed herd; or  
(c) During pre -export isolation each animal was subjected to the following thr ee tests:  
(i) A whole blood sample was tested by RT -PCR with negative results; and  
(ii) A haired skin sample (ear notch or caudal tail fold) was tested by an antigen -capture ELISA test 
with negative results; and  
(iii) A serum sample was tested by virus neutralisation with negative results.  
(15) Brucella abortus  and Brucella melitensis  (brucellosis)  
(a) Each animal has resided, since birth or for at least the 2 years prior to shipment, in a brucellosis ( B. 
abortus  and B. melitensis )-free country and showed no clinical signs of brucellosis on the day of shipment; 
or 
(b) Each animal:  
(i) Was kept since birth or for the 12 months prior to export at zoo premises where no clinical, 
epidemiological or other evidence of brucellosis ( B. abortus  and B. melitensis ) occurred in any 
species during the previous 2 years; and  
(ii) Showed no clinical signs of brucellosis on the day of shipment; and  
(iii) Was tested with an MPI -approved test for brucellosis ( B. abortus  and B. melitensis ) with negative 
results, within the 30 days of export. For post -parturient femal es, the test was carried out at least 
30 days after giving birth.  
(16) Crimean Congo haemorrhagic fever orthonairovirus  
(a) Each animal has resided since birth in a Crimean Congo haemorrhagic fever -free country and showed no 
clinical signs of Crimean Congo haemorrhagic fever on the day of shipment; or  
(b) For the 6 months prior to shipment, each animal resided at zoo premises where no cases of Crimean 
Congo haemorrhagic fever have been reported.  
(17) External parasites  
(a) During pre-export isolation each animal was trea ted twice, at least 14 days apart, with an 
insecticide/acaricide solution effective against ticks , mites , lice, and fleas.  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  33 of 39 
 
 
 Name of ectoparasiticide: ................................................................................................... .......... 
Active ingredient(s): ....................................................................................................... ...............  
Dose rate: .................................................................................................... .................................  
Date of first treatment: ………................................................................................................. ...........  
Date of second treatment: ………........................................................ ....................................................  
(18) Foot and mouth disease (FMD) virus  
(a) Each animal has resided since birth in a country that is officially free from FMD in accordance with the 
Code and showed no clinical signs of FMD on the day of shipment ; or 
(b) Each animal has resided since birth or for at least the 6 months prior to export in a n FMD -free country in 
accordance with the Code or an MPI -approved FMD -free zone and showed no clinical signs of FMD on the 
day of shipment . 
(19) Internal parasites  
(a) During pre-export isolation each animal was treated twice, at least 14 days apart, for nematodes, cestodes 
and trematodes.  
Name of endoparasiticide: ….................................................................................................. ........ ... 
Active ingredient(s): …………………............................................................................................  
Dose rate: …................................................................................................................. ................  
Date of first treatment: ......................................................................................................................  
Date of second treatment: ................................................................................................... ............ ....... 
(20) Mycobacterium bovis  (bovine tuberculosis)  
(a) Each animal has resided since birth in a Mycobacterium bovis -free country and showed no clinical signs of 
bovine tuberculosis on the day of shipment; or  
(b) For the 12 months prior to shipment, each animal resi ded at zoo premises where no clinical, 
epidemiological or other evidence of Mycobacterium bovis  has occurred in the previous 5 years. During 
this time the animals were protected from contact with any reservoir of Mycobacterium bovis  and showed 
no clinical signs of bovine tuberculosis on the day of shipment; or  
(c) During pre -export isolation each animal was subjected to MPI -approved testing for Mycobacterium bovis  
with negative results.  
(21) Pasteurella multocida  (haemorrhagic septicaemia)  
(a) Each animal has resided si nce birth or for at least the 6 months prior to shipment in a Pasteurella 
multocida (B:2 and E:2) -free country and showed no clinical signs of haemorrhagic septicaemia on the day 
of shipment; or  
(b) Each animal was resident for at least the 12 months prior to shipment, at zoo premises where no clinical, 
epidemiological or other evidence of Pasteurella multocida  (B:2 and E:2) occurred during the previous 12 
months and where animals are vaccinated against Pasteurella multocida  (B:2 and E:2) with an               
MPI-approved vaccine.  
(22) Peste des petits ruminants virus (PPRV)  
(a) Each animal has reside d since birth in a peste des petits ruminants -free country and showed no clinical 
signs of peste des petits ruminants on the day of shipment; or  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  34 of 39 
 
 
 (b) Each animal was subjected to an MPI -approved test for peste des petits ruminants within  the 21 days prior 
to shipment with negative results and showed no clinical signs of peste des petits ruminants during pre -
export isolation.  
(23) Rabies  
(a) Each animal has resided since birth or for at least 6 months in a rabies -free county and showed no clinical 
signs of rabies on the day of shipment; or  
(b) For the 6 months prior to shipment each animal was kept at zoo premises where separation from 
susceptible animals was maintained and where there was  no case of rabies for at least 12 months prior to 
shipment; and  
(i) Showed no clinical signs of rabies on the day of shipment.  
(24) Trypanosoma  spp. (surra and tsetse fly associated trypanosomosis)  
(a) Each animal has resided since birth in surra and tsetse fly associ ated trypanosomosis -free countries and 
showed no clinical signs of trypanosomosis on the day of shipment; or  
(b) Each animal:  
(i) Was resident, for at least 6 months prior to shipment, at zoo premises where no clinical, 
epidemiological or other evidence of surra o r tsetse fly associated trypanosomosis has occurred in 
any animal species in the previous 2 years; and  
(ii) During the pre -export isolation, a blood sample was drawn from a peripheral vein of the animals 
and tested for Trypanosoma  spp. using the haematocrit centrifuge technique, and a card 
agglutination test, with negative results.  
 
 Official Veterinarian  
Name:  
Address:  
Email:  
  
Signature:   
Date:  
 
  
Official Veterinarian signature, 
Official stamp and date  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  35 of 39 
 
 
 6.6 Model veterinary certificate T ragulidae semen  
(1) Below is a model veterinary certificate for trade in Tragulidae semen . This can be used by the 
exporting Competent Authority as a reference for country -specific veterinary certificate negotiation, but 
a certificate must be agreed between the exporting Competent Authority and MPI before trade can 
commence.  
 
Part 1: Details of  dispatched consignment  1.1.  Consignor (Exporter):  
Name:  
Address:  
 1.2.  Certificate reference number:  
 
1.3.  Competent Authority:  
 
1.4.  Consignee (Importer):  
Name:  
Address:  
 
 
1.5.  Country of origin:  
ISO Code*  1.6.  Zone or compartment of origin:**  
 
1.7.  Country of destination :  
ISO Code*  1.8.  Zone o r compartment of destination:**  
1.9.  Place of origin:  
Name:  
Address:  
1.10.  Place of shipment:  1.11.  Date of departure:  
1.12.  Means of transport:  
 
    Aeroplane           Ship  
 
Identification:  
 1.13.  Expected border post:  
1.14.  CITES permit No(s):**  
1.15.  Description of commodity:  
 1.16.  Commodity Code (ISO Code*):  
1.17.  Total number of:  
1.18.  Temperature of commodities for transport:  
 1.19.  Total number of packages:  
1.20.  Identification of container/serial number:  
 1.21.  Type of packaging:  
1.22.  Identification of commodity:  Tragulidae  (semen)  
Species (Scientific Name)  ID Number/Details  Breed/Category  Age Quantity  ID System  
      
      
      
 
* Optional  ** If referenced in Part 2  
 Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  36 of 39 
 
 
 
Part 2:  Veterinary Information  Country:  Certificate reference number:  
I, the undersigned Official Veterinarian, certify that the semen described above satisf ies the following requirements:   
 
Semen donor requirements  
(1) The donor males were  resident in an approved, licensed or registered zoo or wildlife park since birth or for at least 
12 months immediately before semen collection . 
(2) The donor males were not under quarantine restriction for the collection period or the 90 days immediately prior 
collection.  
(3) The zoo or wildlife par k in which the donor males have been resident were  under permanent veterinary 
supervision, and a health monitoring programme was followed including necropsies, and microbiological and 
parasitology testing.  
(4) The donor males were  free from clinical evidence of  infectious disease transmissible in semen on the day of 
semen collection and for the 30 days immediately after.  
Semen collection, processing, storage, and transport requirements  
(5) Personnel collecting and processing semen were trained in, and practice d, proper disinfection procedures and 
hygiene techniques.  
(6) All equipment and working surfaces likely to come into contact with semen for export have been appropriately 
cleaned and disinfected.  
(7) All semen straws, ampoules or containers were identified with the d onor animals and the date of collection.  
(8) All products of animal origin, other than egg yolk, used in collection, processing and storage of the semen were 
sterile preparations or were screened for adventitious viruses with negative results.  
(9) Any cryogenic or  cooling agent used in the freezing process, storage, and transport was not used previously in 
association with any other product of animal origin.  
(10) The collection and transport containers are new or disinfected, and free of contamination.  
(11) The semen was stored in a secure area prior to export . 
(12) The transport container in which the semen is transported to New Zealand was sealed, by either the registered 
veterinarian supervising the collection or an Official Veterinarian, using tamper -evident seals.  
Seal number __________________________________________  
Tests and treatments (delete as appropriate ) 
(13) Bovine viral diarrhoea virus (BVDV) 2 and BVDV 3  
(a) Each donor male has been resident since birth in a BVDV 2 and BVDV 3 -free country and showed no 
clinical signs o f BVD on the day of semen collection; or  
(b) For the 6 months prior to shipment, each donor male resided at zoo premises, where no clinical, 
epidemiological or other evidence of BVDV 2 and BVD 3 occurred in the previous 12 months. A screening 
programme was in place and include d MPI-approved diagnostic testing of all animals in the collection prior 
to donor males entering the collection. The diagnostic tests were  able to identify infected and persistently 
infected animals and the collection was a closed herd; or  
(c) The semen was tested by a virus isolation or real -time RT -PCR for BVDV; or  
(d) Each donor male was tested by the following protocols during semen collection:  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  37 of 39 
 
 
 (i) A whole blood sample from the donor animals was tested by RT -PCR. The test result was negative 
for B VDV; and  
(ii) A haired skin sampled (ear notch or caudal tail fold) from the animal(s) was tested by an antigen -
capture ELISA test. The test result was negative; and  
(iii) A serum sample from the animal was tested by virus neutralisation. The test result was negativ e. 
(14) Brucella abortus  and Brucella melitensis  (brucellosis)  
(a) Each donor male was resident since birth or for at least the 2 years prior to semen collection, in a 
brucellosis ( B. abortus  and B. melitensis )-free country and showed no clinical signs of brucellos is on the 
day of collection; or  
(b) Each donor male:  
(i) Was kept since birth or for 12 months immediately prior to semen collection at a zoo premise s 
where no clinical, epidemiological or other evidence of brucellosis ( B. abortus  and B. melitensis ) 
has occurred in any species during the previous 2 years; and  
(ii) Showed no clinical signs of brucellosis on the day of semen collection; and  
(iii) Was subjected to an MPI -approved test for brucellosis ( B. abortus  and B. melitensis ) within the 30 
days after collec tion with negative results; or  
(iv) A straw from each semen sample was tested for brucellosis ( B. abortus  and B. melitensis ) with an 
MPI-approved test with negative results.  
(15) Foot and mouth disease (FMD) virus  
(a) Each donor male has been resident since birth in a c ountry that is officially free from FMD in accordance 
with the Code and showed no clinical signs of FMD on the day of semen collection; or  
(b) Each donor male:  
(i) Showed no clinical signs of FMD on the day of semen collection and for the following 30 days; and  
(ii) Was resident for at least the 6 months prior to collection in an FMD -free country in accordance with 
the Code where vaccination is not practised or in an FMD -free zone; or  
(c) Each donor male:  
(i) Showed no clinical signs of FMD on the day of semen collection and for the following 30 days; and  
(ii) Was resident since birth or for at least 6 months at a facility where no animal had been added in 
the 30 days before semen collection and no FMD had occurred within a 10 -kilometre radius of the 
facility for the 30 days befor e and after collection; and  
(iii) A straw from each semen sample was subjected to an MPI -approved test for FMDV with negative 
results and the semen was stored in the country of origin for a period of at least one month 
following collection. During this period, n o animal at the facility where the donor males were kept 
showed any sign of FMD.  
(16) Mycobacterium bovis  (bovine tuberculosis)  
(a) Each donor male has been resident since birth in a Mycobacterium bovis -free country and showed no 
clinical signs of bovine tuberculos is on the day of semen collection; or  
(b) For the 12 months prior to semen collection, each donor male resided on a premise s where no clinical, 
epidemiological or other evidence of Mycobacterium bovis  has occurred during the previous 3 years. 
During this time  the donor males have been protected from contact with any reservoir of Mycobacterium 
bovis  and showed no clinical signs of bovine tuberculosis on the day of semen collection; or  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  38 of 39 
 
 
 (c) Each donor male was subjected to MPI -approved testing for Mycobacterium bovis  with negative results; or  
(d) At least 3 straws from each collection batch of semen from each donor animals were tested via PCR, with 
negative results.  
(17) Peste des petits ruminants virus (PPRV)  
(a) Each donor male has been resident since birth in a peste des petits  ruminants -free country and showed no 
clinical signs of peste des petits ruminants on the day of semen collection; or  
(b) Each donor male:  
(i) Was kept, for at least 21 days prior to collection, at a zoo premise s where no case of peste des 
petits ruminants was rep orted during that period, which was not situated in a peste des petits 
ruminants infected zone and to which no animals had been added during the 21 days prior to 
collection; and  
(ii) Showed no clinical signs of peste des petits ruminants for at least 21 days pr ior to collection of 
semen and during the following 21 days; and  
(iii) Was tested with an MPI -approved test for peste des petits ruminants with negative results, at least 
21 days prior to collection of semen; or  
(iv) A straw of semen from each collection batch was te sted for peste des petits ruminants with an 
MPI-approved test and was negative.  
 
 Official Veterinarian  
Name:  
Address:  
Email:  
  
Signature:   
Date:  
 
 
  
Official Veterinarian signature, 
Official stamp and date  Guidance Document : Zoo Bovidae, Giraffidae and Tragulidae (Live Animals and Semen)  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  39 of 39 
 
 
 Appendix 1 – Document History  
Date First Issued  Title Shortcode  
Date  Guidance Document:  Zoo Bovidae, Giraffidae 
and Tragulidae (Live Animals and Semen)  GD ZOORUMIN.SPE  
Date of Issued Amendments  Title Shortcode